Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | -29.05%1.35B | -12.24%1.9B | 45.89%2.17B | 11.83%1.48B | 74.15%1.33B | -50.39%762M | 59.50%1.54B | 125.53%963M | -33.39%427M | -32.17%641M |
| Net profit before non-cash adjustment | 5.26%1.82B | -6.18%1.73B | 7.27%1.84B | 25.57%1.72B | 34.61%1.37B | 2.42%1.02B | 1.12%993M | -0.30%982M | 17.82%985M | -23.93%836M |
| Total adjustment of non-cash items | -150.25%-102M | 61.11%203M | 2,000.00%126M | -95.80%6M | 448.78%143M | -310.00%-41M | -141.67%-10M | 143.64%24M | -190.16%-55M | 108.32%61M |
| -Depreciation and amortization | -52.63%18M | -15.56%38M | -11.76%45M | 21.43%51M | 0.00%42M | 50.00%42M | -17.65%28M | -8.11%34M | 37.04%37M | -6.90%27M |
| -Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -52.94%32M |
| -Disposal profit | ---- | ---- | ---- | ---- | ---- | ---1M | --0 | 93.75%-1M | -159.26%-16M | 575.00%27M |
| -Pension and employee benefit expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 97.12%-24M |
| -Other non-cash items | -172.73%-120M | 103.70%165M | 280.00%81M | -144.55%-45M | 223.17%101M | -115.79%-82M | -322.22%-38M | 88.16%-9M | -7,500.00%-76M | 50.00%-1M |
| Changes in working capital | -1,027.27%-372M | -116.84%-33M | 181.33%196M | -28.88%-241M | 13.43%-187M | -139.06%-216M | 1,386.05%553M | 91.45%-43M | -96.48%-503M | -144.21%-256M |
| -Change in receivables | -2,060.00%-540M | -107.04%-25M | 184.52%355M | -67.33%-420M | -234.67%-251M | -130.86%-75M | 222.73%243M | 63.60%-198M | -555.42%-544M | -396.43%-83M |
| -Change in inventory | -46.15%7M | -56.67%13M | 183.33%30M | -300.00%-36M | -64.00%18M | 208.70%50M | -291.67%-46M | 172.73%24M | -3,200.00%-33M | 90.91%-1M |
| -Change in payables | 389.66%84M | 65.48%-29M | -157.53%-84M | 2,333.33%146M | 118.18%6M | -127.73%-33M | 50.63%119M | 83.72%79M | 171.67%43M | -115.75%-60M |
| -Change in accrued expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -166.27%-112M |
| -Provision for loans, leases and other losses | 862.50%77M | 107.62%8M | -264.06%-105M | 120.69%64M | 252.63%29M | -147.50%-19M | 81.82%40M | 466.67%22M | ---6M | ---- |
| -Changes in other current assets | ---- | ---- | ---- | -54.55%5M | 108.46%11M | -165.99%-130M | 556.67%197M | -18.92%30M | --37M | --0 |
| -Changes in other current liabilities | ---- | ---- | ---- | ---- | ---- | ---9M | ---- | ---- | ---- | ---- |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | ||||||||||
| Interest received (cash flow from operating activities) | 1M | 0 | 0 | 0 | 0 | 0.00%1M | 0.00%1M | -50.00%1M | -33.33%2M | 0.00%3M |
| Tax refund paid | -13.67%-582M | 12.63%-512M | -9.33%-586M | -114.40%-536M | 25.37%-250M | -1.21%-335M | -24.44%-331M | -1.14%-266M | -25.84%-263M | 54.96%-209M |
| Other operating cash inflow (outflow) | -200.00%-1M | 1M | 0 | 0 | 0 | 0 | -1M | 0 | 0 | 0 |
| Operating cash flow | -44.85%766M | -12.03%1.39B | 66.56%1.58B | -11.98%948M | 151.64%1.08B | -64.48%428M | 72.64%1.21B | 320.48%698M | -61.84%166M | -10.12%435M |
| Investing cash flow | ||||||||||
| Capital expenditures | ---- | ---- | ---- | ---- | ---- | ---- | 21.79%-61M | ---78M | ---- | ---- |
| Net PPE purchase and sale | -2,600.00%-27M | ---1M | --0 | -12.20%-46M | -127.78%-41M | ---18M | ---- | ---- | 75.76%-24M | -482.35%-99M |
| Net intangibles purchase and sale | --5M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net investment product transactions | --0 | 81.25%29M | 153.33%16M | -372.73%-30M | -52.17%11M | -32.35%23M | 1,600.00%34M | -94.74%2M | 245.45%38M | 134.38%11M |
| Net changes in other investments | -100.00%-10M | -400.00%-5M | ---1M | ---- | ---8M | ---- | 54.17%-11M | -108.14%-24M | 283.23%295M | -22.90%-161M |
| Investing cash flow | -239.13%-32M | 53.33%23M | 119.74%15M | -100.00%-76M | -860.00%-38M | 113.16%5M | 62.00%-38M | -132.36%-100M | 224.10%309M | -38.33%-249M |
| Financing cash flow | ||||||||||
| Net common stock issuance | 99.25%-1M | -13,200.00%-133M | 50.00%-1M | 98.96%-2M | ---193M | --0 | --0 | --0 | --0 | --0 |
| Cash dividends paid | -0.39%-509M | -0.20%-507M | -45.40%-506M | -42.62%-348M | 0.00%-244M | -5.63%-244M | -11.59%-231M | -8.95%-207M | -16.56%-190M | -33.61%-163M |
| Net other fund-raising expenses | ---- | ---- | ---- | --3M | ---- | ---- | ---1M | ---- | ---- | ---- |
| Financing cash flow | 20.31%-510M | -26.23%-640M | -46.11%-507M | 20.59%-347M | -79.10%-437M | -5.17%-244M | -12.08%-232M | -8.95%-207M | -16.56%-190M | -33.61%-163M |
| Net cash flow | ||||||||||
| Beginning cash position | 10.54%8.1B | 17.45%7.32B | 9.19%6.24B | 11.78%5.71B | 3.84%5.11B | 23.49%4.92B | 10.85%3.98B | 8.58%3.59B | 0.67%3.31B | 5.86%3.29B |
| Current changes in cash | -70.98%224M | -28.98%772M | 107.05%1.09B | -12.79%525M | 218.52%602M | -79.79%189M | 139.13%935M | 37.19%391M | 1,139.13%285M | -87.36%23M |
| Cash adjustments other than cash changes | ---1M | ---- | --1M | ---- | ---- | ---- | 200.00%1M | 0.00%-1M | 0.00%-1M | ---1M |
| End cash Position | 2.75%8.32B | 10.54%8.1B | 17.45%7.32B | 9.19%6.24B | 11.78%5.71B | 3.84%5.11B | 23.49%4.92B | 10.85%3.98B | 8.58%3.59B | 0.67%3.31B |
| Free cash flow | -46.76%739M | -12.10%1.39B | 75.06%1.58B | -12.93%902M | 152.68%1.04B | -64.16%410M | 84.52%1.14B | 336.62%620M | -57.74%142M | -28.05%336M |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |